Article
Small molecule FICD inhibitors suppress endogenous and pathologic FICD-mediated protein AMPylation
2024-07-16
Abstract excerpt
<h4>Summary</h4> The AMP transferase, FICD, is an emerging drug target finetuning stress signaling in the endoplasmic reticulum (ER). FICD is a bi-functional enzyme, catalyzing both AMP addition (AMPylation) and removal (deAMPylation) from the ER resident chaperone BiP/GRP78. Despite increasing evidence linking excessive BiP/GRP78 AMPylation to human diseases, small molecules to inhibit pathogenic FICD variants a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 86cf115c-ea5a-5044-a6dd-c9fcb78fc6dc
- DOI
- 10.1101/2024.07.13.603377
